ATPW
RMD icon

Ashton Thomas Private Wealth’s ResMed RMD Stock Holding History

Ashton Thomas Private Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$320K Buy
+1,426
New +$355K 0.01% 863
2024
Q3 		– Sell
-37
Closed -$7.08K – 1564
2024
Q2 		$7.08K Buy
+37
New +$7.51K ﹤0.01% 1438

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ashton Thomas Private Wealth's RMD Position: Q1 2026 in Review

Ashton Thomas Private Wealth opened a new position in ResMed (RMD) in Q1 2026: 1,426 shares worth $320K. The stake represents 0.01% of the portfolio and ranks #863 among its holdings. This is a return to the name: Ashton Thomas Private Wealth previously reported a position in RMD as recently as Q2 2024.

Ashton Thomas Private Wealth first reported a position in RMD in Q2 2024 and has held it in 2 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Ashton Thomas Private Wealth held 1,426 shares of ResMed worth $320K as of Q1 2026.
  • ResMed was a new Ashton Thomas Private Wealth position in Q1 2026.
  • ResMed made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q1 2026, its #863 holding.
  • Ashton Thomas Private Wealth first reported a position in ResMed in Q2 2024 and has held it in 2 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.